April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Structure-Function Relationship in Glaucoma Using the Cirrus Spectral Domain Optical Coherence Tomograph and Standard Automated Perimetry
Author Affiliations & Notes
  • M. T. Leite
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • L. M. Zangwill
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
  • R. N. Weinreb
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
  • P. A. Sample
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
  • H. L. Rao
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
    L V Prasad Eye Institute, Hyderabad, India
  • L. M. Alencar
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
    Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil
  • C. Bowd
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
  • F. A. Medeiros
    Ophthalmology, Hamilton Glaucoma Center, Univ of California-San Diego, La Jolla, California
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  M.T. Leite, None; L.M. Zangwill, Carl Zeiss Meditec, Inc., F; Heidelberg Engineering, GmbH, F; Optovue, Inc., F; Topcon Medical Systems, Inc., F; R.N. Weinreb, Carl Zeiss Meditec, Inc., F; Heidelberg Engineering, GmbH, F; Optovue, Inc., F; Topcon Medical Systems, Inc., F; Novartis, F; Alcon Laboratories, Inc., C; Allergan, Inc., C; Carl Zeiss Meditec, Inc., C; Glaxo, C; Optovue, Inc., C; Topcon Medical System, Inc., C; Pfizer, C; P.A. Sample, Carl Zeiss Meditec, Inc., F; Haag-Streit, F; Welch-Allyn, F; H.L. Rao, None; L.M. Alencar, None; C. Bowd, Lace Elettronica, F; F.A. Medeiros, Carl Zeiss Meditec, Inc., F; Pfizer, F; AlconLaboratories, Inc., F; Alcon Laboratories, Inc., C; Allergan, Inc., C; Pfizer, Inc., C; Alcon Laboratories, Inc., R; Allergan, Inc., R; Carl Zeiss Meditec, Inc., R; Pfizer, Inc., R; Reichert, Inc., R.
  • Footnotes
    Support  NEI R01-EY08208 (PAS), NEI R01-11008 (LMZ)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4909. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. T. Leite, L. M. Zangwill, R. N. Weinreb, P. A. Sample, H. L. Rao, L. M. Alencar, C. Bowd, F. A. Medeiros; Structure-Function Relationship in Glaucoma Using the Cirrus Spectral Domain Optical Coherence Tomograph and Standard Automated Perimetry. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4909.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To evaluate the relationship between glaucomatous structural damage assessed by the Cirrus Spectral Domain OCT (SDOCT) and functional loss as measured by standard automated perimetry (SAP).

 
Methods:
 

Four hundred twenty two eyes (78 healthy, 210 suspects, 134 glaucomatous) of 250 patients were recruited from the longitudinal Diagnostic Innovations in Glaucoma Study (DIGS). All eyes underwent testing with the Cirrus SDOCT and SAP within a 6-month period. The relationship between parapapillary retinal nerve fiber layer thickness (RNFL) sectors and corresponding topographic SAP locations was evaluated using LOWESS and regression analysis. SAP sensitivity values were evaluated using both linear as well as logarithmic scales. We also tested the fit of a proposed model for structure-function relationship in glaucoma suggested by Hood et al.(Prog Retin Eye Res, 2007).

 
Results:
 

Structure was significantly related to function for all but the nasal thickness sector. The relationship was strongest for superotemporal RNFL thickness and inferonasal sensitivity, both using SAP sensitivity in a linear (R2 = 0.314, P<0.001) and logarithmic scale (R2 = 0.286, P<0.001). The model proposed by Hood et al. fitted the data relatively well with 88% of the eyes inside the 95% confidence interval predicted by the model (Figure 1).

 
Conclusions:
 

RNFL thinning measured by the Cirrus SDOCT was associated with correspondent visual field loss in glaucoma.  

 
Keywords: imaging/image analysis: clinical • nerve fiber layer • visual fields 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×